Genetic determinants of adenomyosis
Adenomyosis is defined as the presence of endometrial-like tissue within the myometrium. It is a multifactorial disease with possible genetic predisposition. This article presents the results of the studies carried out within the framework of three approaches: association analysis, gene expression study and somatic mutation study. According to the classical concepts, the genetic predisposition to multifactorial diseases (including adenomyosis) depends on the presence of a certain set of polymorphic gene variants in a person. Such investigations are very few in adenomyosis; most of the studies are devoted to the analysis of gene variants whose products are involved in the synthesis and metabolism of estrogens, neoangiogenesis and remodeling of the extracellular matrix. Moreover, epigenetic mechanisms of adenomyosis can cause long-term changes in the expression of individual genes or entire blocks of genes due to DNA methylation, changes in the structure of chromatin, and non-coding RNAs. The article highlights a new area of research devoted to the study of the role of somatic mutations in adenomyosis. In comparison with other tissues, the endometrial glands of healthy women carry a particularly large number of somatic mutations, while stromal cells mostly remain intact. Somatic mutations in epithelial cells are also found in the ectopic endometrium of patients with adenomyosis and extragenital endometriosis. The spectra of somatic mutations detected in the ectopic endometrium in extragenital endometriosis and adenomyosis have their own characteristics and they are different in these two diseases.Malysheva O.V., Yarmolinskaya M.I.
Conclusion: The above genetic aspects of pathogenic mechanisms of adenomyosis indicate that this disease has a polyetiological origin. The presence of unfavorable alleles that impair the functioning of gene networks associated with the pathogenesis of the disease, long-term changes in gene expression followed by disorders in tissue homeostasis in target organs, and appearance of somatic mutations in the cells of the glands of the ectopic and eutopic endometrium are the factors that together can lead to the development of this pathology.
Authors’ contributions: Malysheva O.V., Yarmolinskaya M.I. – developing the concept and design of the study, collecting and processing the material; Malysheva O.V. – writing the text; Yarmolinskaya M.I. – editing the article.
Conflicts of interest: The authors declare that there are no conflicts of interest.
Funding: The study was conducted within the framework of the Basic Scientific Research project, “Strategy of preserving the health of women with gynecological and endocrine diseases in different age periods: pathogenetic rationale for drug rehabilitation and development of new directions of organ‑preserving surgical interventions”, No. 122041500063‑2.
For citation: Malysheva O.V., Yarmolinskaya M.I. Genetic determinants of adenomyosis. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2023; (4): 20-27 (in Russian)
https://dx.doi.org/10.18565/aig.2023.52
Keywords
adenomyosis
genetic predisposition
single nucleotide polymorphism
genotype
gene expression
somatic mutation
DNA methylation
miRNA
References
1. Emge L.A. The elusive adenomyosis of the uterus: its historical past and its present state of recognition. Am. J. Obstet. Gynecol. 1962; 83(12): 1541‑63. https://dx.doi.org/10.1016/0002‑9378(62)90170‑9.
2. Arnold L.L., Ascher S.M., Simon J.A. Familial adenomyosis: a case report. Fertil. Steril. 1994; 61(6): 1165‑7. https://dx.doi.org/10.1016/s0015‑0282(16)56776‑4.
3. Templeman C., Marshall S.F., Ursin G., Horn-Ross P.L., Clarke C.A., Allen M. et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil. Steril. 2008; 90(2): 415‑24. https://dx.doi.org/10.1016/j.fertnstert.2007.06.027.
4. Баранов В.С., ред. Эволюция предиктивной медицины. СПб.: Эко‑Вектор; 2021. 359с. [Baranov V.S., ed. Evolution of predictive medicine. St. Petersburg: Eko‑Vector; 2021. 359 p. (in Russian)].
5. Франциянц Е.М., Бандовкина В.А., Моисеенко Т.И., Черникова Н.В. Уровень половых гормонов в тканях аденомиоза и миомы матки при самостоятельном и сочетанном развитии. Российский онкологический журнал. 2013; 6: 24‑7. [Frantsiyants E.M., Bandovkina V.A., Moiseenko T.I., Chernikova N.V. The level of sex hormones in the tissues and myoma adenomyosis at the independent and combined development. Russian Oncological Journal. 2013; (6): 24‑7. (in Russian)].
6. Kitawaki J., Obayashi H., Ishihara H., Koshiba H., Kusuki I., Kado N. et al. Oestrogen receptor‑alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum. Reprod. 2001; 16(1): 51‑5. https://dx.doi.org/10.1093/humrep/16.1.51.
7. Hong D.G., Park J.Y., Chong G.O., Lee Y.H., Lee H.J., Shinn J.U. et al. Transmembrane G protein‑coupled receptor 30 gene polymorphisms and uterine adenomyosis in Korean women. Gynecol. Endocrinol. 2019; 35(6): 498‑501. https://dx.doi.org/10.1080/09513590.2018.1540572.
8. Artymuk N., Zotova O., Gulyaeva L. Adenomyosis: genetics of estrogen metabolism. Horm. Mol. Biol. Clin. Investig. 2019; 37(2). https://dx.doi.org/10.1515/ hmbci‑2018‑0069.
9. Juo S.H., Wang T.N., Lee J.N., Wu M.T., Long C.Y., Tsai E.M. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women. Hum. Reprod. 2006; 21(6): 1498‑502. https://dx.doi.org/10.1093/humrep/ del033.
10. Tong X., Li Z., Wu Y., Fu X., Zhang Y., Fan H. COMT 158G/A and CYP1B1 432C/G polymorphisms increase the risk of endometriosis and adenomyosis: a meta‑analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014; 179: 17‑21. https://dx.doi.org/10.1016/j.ejogrb.2014.04.039.
11. Kang S., Zhao J., Liu Q., Zhou R., Wang N., Li Y. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Environ. Mol. Mutagen. 2009; 50(5): 361‑6. https://dx.doi.org/10.1002/em.20455.
12. Liu Q., Li Y., Zhao J., Zhou R.M., Wang N., Sun D.L. et al. Association of single nucleotide polymorphisms in VEGF gene with the risk of endometriosis and adenomyosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009; 26(2): 165‑9. https://dx.doi.org/10.3760/cma.j.issn.1003‑9406.2009.02.010.
13. Kang S., Li S. Z., Wang N., Zhou R.M., Wang T., Wang D.J. et al. Association between genetic polymorphisms in fibroblast growth factor (FGF) 1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women. Hum. Reprod. 2010; 25(7): 1806‑11. https://dx.doi.org/10.1093/humrep/deq128.
14. Ye H., He Y., Wang J., Song T., Lan Z., Zhao Y., Xi M. Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta‑analysis. J. Genet. 2016; 95(3): 611‑9. https://dx.doi.org/10.1007/s12041‑016‑0675‑5.
15. Kang S., Zhao X., Xing H., Wang N., Zhou R., Chen S. et al. Polymorphisms in the matrix metalloproteinase‑2 and tissue inhibitor of metalloproteinase‑2 and the risk of human adenomyosis. Environ. Mol. Mutagen. 2008; 49(3): 226‑31. https://dx.doi.org/10.1002/em.20375.
16. Wang Y., Qu Y., Song W. Genetic variation in COX‑2‑1195 and the risk of endometriosis and adenomyosis. Clin. Exp. Obstet. Gynecol. 2015; 42(2): 168‑72.
17. Liu X., Guo S.W. Aberrant immunoreactivity of deoxyribonucleic acid methyltransferases in adenomyosis. Gynecol. Obstet. Invest. 2012; 74(2): 100‑8. https://dx.doi.org/1010.1159/000337718.
18. Liu X., Nie J., Guo S.W. Elevated immunoreactivity against class I histone deacetylases in adenomyosis. Gynecol. Obstet. Invest. 2012; 74(1): 50‑5. https://dx.doi.org/1010.1159/000336409.
19. Xiang Y., Sun Y., Yang B., Yang Y., Zhang Y., Yu T. et al. Transcriptome sequencing of adenomyosis eutopic endometrium: a new insight into its pathophysiology. J. Cell. Mol. Med. 2019; 23(12): 8381‑91. https://dx.doi.org/1010.1111/jcmm.14718.
20. Herndon C.N., Aghajanova L., Balayan S., Erikson D., Barragan F., Goldfien G. et al. Global transcriptome abnormalities of the eutopic endometrium from women with adenomyosis. Reprod. Sci. 2016; 23(10): 1289‑303. https://dx.doi.org/10.1177/1933719116650758.
21. Малышева О.В., Беганова А.К., Вашукова Е.С., Шалина М.А., Ярмолинская М.И., Глотов А.С. Роль сигнальных каскадов WNT и HOX в патогенезе аденомиоза. Журнал акушерства и женских болезней. 2023; 72(1): 27‑37. [Malysheva O.V., Beganova A.K., Vashukova E.S., Shalina M.A., Yarmolinskaya M.I., Glotov A.S. The role of signaling cascades WNT and HOX in the pathogenesis of adenomyosis. Journal of Obstetrics and Women's Diseases. 2023; 72(1): 27‑37. (in Russian)]. https://dx.doi.org/10.17816/ JOWD121803.
22. Makinen N., Mehine M., Tolvanen J., Kaasinen E., Li Y., Lehtonen H.J. et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011; 334(6053): 252‑5. https://dx.doi.org/10.1126/ science.1208930.
23. Bulun S.E., Sule Yildiz S., Adli M., Wei J. Adenomyosis pathogenesis: Insights from next‑generation sequencing. Hum. Reprod. Update. 2021; 27(6): 1086‑97. https://dx.doi.org/10.1093/humupd/dmab017.
24. Moore L., Leongamornlert D., Coorens T.H.H., Sanders M.A., Ellis P., Dentro S.C. et al. The mutational landscape of normal human endometrial epithelium. Nature. 2020; 580(7805): 640‑6. https://dx.doi.org/10.1038/s41586‑020‑2214‑z.
25. Inoue S., Hirota Y., Ueno T., Fukui Y., Yoshida E., Hayashi T., Inoue S. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations. Nat. Commun. 2019; 10(1): 5785. https://dx.doi.org/10.1038/s41467‑019‑13708‑y.
26. Ярмолинская М.И., Шалина М.А., Хачатурян А.Р., Нетреба Е.А., Флорова М.С., Мехтиханова С.В. Аденомиоз: от научных открытий к практическим аспектам назначения медикаментозной терапии. Акушерство и гинекология. 2020; 3: 182‑90. [Yarmolinskaya M.I., Shalina M.A., Khachaturyan A.R., Netreba E.A., Florova M.S., Mekhtikhanova S.V. Adenomyosis: from scientific discoveries to the practical aspects of prescribing drug therapy. Obstetrics and Gynecology. 2020; (3): 182‑90. (in Russian)]. https://dx.doi.org/10.18565/ aig.2020.3.182‑190.
27. Аксененко А.А., Гус А.И., Мишиева Н.Г. Аденомиоз и бесплодие. Акушерство и гинекология. 2021; 4: 41‑7. [Aksenenko A.A., Gus A.I., Mishieva N.G. Adenomyosis and infertility. Obstetrics and Gynecology. 2021; (4): 41‑7. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.4.41‑47.
Received 01.03.2023
Accepted 29.03.2023
About the Authors
Olga V. Malysheva, Senior Researcher, Laboratory of Genomics, D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology, +7(812)328-98-09, omal99@mail.ru, https://orcid.org/0000-0002-8626-5071, 199034, Russia, St. Petersburg, Mendeleyevskaya liniya, 3.Maria I. Yarmolinskaya, Professor of RAS, Dr. Med. Sci., Head of the Department of Gynecology and Endocrinology, D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology, 199034, Russia, St. Petersburg, Mendeleyevskaya liniya, 3; Professor, Department of Obstetrics and Gynecology, I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia, 191015, Russia, St. Petersburg, Kirochnaya str., 41, m.yarmolinskaya@gmail.com, https://orcid.org/0000-0002-6551-4147 Corresponding author: Olga V. Malysheva, omal99@mail.ru
Similar Articles
